ClinicalTrials.gg
RecruitingNCT06230172Updated Feb 7, 2024

Early Weaning From Incubator To Crib

An interventional study of Weaning incubator (heat) at an lower postnatal weight in Hypothermia, Newborn, Body Temperature Changes and Newborn Thermal Injury, sponsored by Augusta University. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2024-02-07.

Sponsored by Augusta University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Sex
All
01

Study summary

The purpose of this study is to determine the safety and feasibility of weaning from the incubator at a lower post-natal weight at 1600 grams. Our hypothesis is that early weaning from the incubator to a crib/bassinet is safe and may result in a decrease in length of hospital stay while maintaining appropriate growth velocity. Specific outcomes the investigators will evaluate are the length of hospital stay and growth velocity at early weaning.

02

Conditions studied

  • Hypothermia, Newborn
  • Body Temperature Changes
  • Newborn Thermal Injury
03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 50 is below the median of 77 across 328 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Augusta University is the lead sponsor of 180 studies on the registry; 24 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 3 (30%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants with a birth weight \<1600 gm

Exclusion criteria

Exclusion Criteria:

  • Infants who have bradycardia (HR\<80 bpm) that require stimulation for resolution.
  • Infants who require phototherapy.
  • Infants who require respiratory support >2 liter per minute flow by nasal cannula, oxygen need can vary between 21-100%.
  • Infants with major congenital anomalies
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Prospective group (>1600 grams)

    The prospective group is weaned from incubator to crib at a postnatal weight of \>1600 grams following consent process.

    Radiation: Weaning incubator (heat) at an lower postnatal weight

Interventions

  • RadiationWeaning incubator (heat) at an lower postnatal weight

    Infants in the intervention group are weaned in the same manner as the infants in the control arm; however, the wean begins at a lower postnatal weight. Our institutional guidelines for weaning infants from incubator to crib was unchanged for both groups.

06

What researchers measure

Primary outcomes

  1. Length of hospital stay

    Duration of hospital stay

    Time frame: From birth date to hospital discharge, assessed up to 52 weeks

Secondary outcomes

  1. Growth velocity

    Weight gain following wean from incubator to crib

    Time frame: From birth date to hospital discharge, assessed up to 52 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zecca E, Corsello M, Priolo F, Tiberi E, Barone G, Romagnoli C. Early weaning from incubator and early discharge of preterm infants: randomized clinical trial. Pediatrics. 2010 Sep;126(3):e651-6. doi: 10.1542/peds.2009-3005. Epub 2010 Aug 9. PubMed 20696729 ↗
  • Shankaran S, Bell EF, Laptook AR, Saha S, Newman NS, Kazzi SNJ, Barks J, Stoll BJ, Bara R, Gabrio J, Childs K, Das A, Higgins RD, Carlo WA, Sanchez PJ, Carlton DP, Pavageau L, Malcolm WF, D'Angio CT, Ohls RK, Poindexter BB, Sokol GM, Van Meurs KP, Colaizy TT, Khmour A, Puopolo KM, Garg M, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health, and Human Development Neonatal Research Network. Weaning of Moderately Preterm Infants from the Incubator to the Crib: A Randomized Clinical Trial. J Pediatr. 2019 Jan;204:96-102.e4. doi: 10.1016/j.jpeds.2018.08.079. Epub 2018 Oct 15. Erratum In: J Pediatr. 2020 Mar;218:e5. doi: 10.1016/j.jpeds.2020.01.007. PubMed 30337189 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06230172
Lead sponsor
Augusta University
Responsible party
Sponsor
First posted
Jan 30, 2024
Start date
Jul 21, 2023
Primary completion
Jul 21, 2024 (estimated)
Completion
Jul 21, 2024 (estimated)
Last update
Feb 7, 2024

Study contacts

Victor M Ayulo, MD
Contact
vayulo@augusta.edu
9128162144

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion